About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, September 23rd, 2014

The QualityStocks
Daily Stock List


Standard Metals Processing, Inc. (SMPR)

We are reporting on Standard Metals Processing, Inc. (SMPR) today, here at the QualityStocks Daily Newsletter.

Standard Metals Processing, Inc. is a developing, custom toll milling and processing company. The Company facilitates the extraction of precious, strategic, industrial, and rare earth minerals from mined material. It is currently in the process of acquiring the required permits to conduct custom permitted processing toll milling activities and the construction of additional buildings so it can commence operations. Standard Metals Processing lists on the OTC Markets’ OTCQB.

On March 15, 2011, the Company closed a series of transactions, wherein it acquired certain assets of Shea Mining & Milling, LLC , which assets include land, buildings, a dormant milling facility, abandoned milling equipment, water permits, mine tailings, mine dumps and the assignment of a note payable, a lease and a contract agreement with permits. Standard completed the Shea Exchange Agreement to acquire the Shea Mining assets and develop a toll milling services business of precious minerals.

Concerning toll milling, it is a process where mined material is crushed and ground into fine particles to ease the extraction of any precious minerals contained therein, such as gold, silver, lead, zinc and copper, and rare earth metals. Custom milling and refining can include many different processes to extract precious metals from carbon or concentrates.

These toll-processing services also distill, dry, mix, or mill chemicals and bulk materials on a contractual basis. Furthermore, toll-processing services provide a chemical production outsourcing option for industrial companies that lack the expertise, capacity, or regulatory permits for in-house production.

Standard Metals Processing announced in January 2014 that via its subsidiary company, Tonopah Custom Processing, Inc., a Memorandum of Understanding (MOU) to process source material for Adriat Management Group was executed. With this Agreement, the Company will take delivery of high grade gold concentrate and source material that will be processed into refined gold and/or dore bars. Adriat Management Group is a private owner and operator with mining interests in the Caribbean, Central America and South America.

Recently, Standard Metals Processing and Tonopah Custom Processing announced the purchase of a broad array of heavy-duty construction and milling equipment. This is for use in the construction and operation of the Tonopah milling facility.

Standard Metals Processing, Inc. (SMPR), closed Tuesday's trading session at $1.65, up 1.23%, on 11,500 volume with 6 trades. The average volume for the last 60 days is 9,017 and the stock's 52-week low/high is $0.32/$2.57.


Today we are reporting on CDEX, Inc. (CDEX), here at the QualityStocks Daily Newsletter.

CDEX, Inc. is a ground-breaking developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets. Its proprietary solutions are based on its patented Enhanced Photoemission Spectroscopy technology for substance verification, authentication and identification. CDEX lists on the OTC Markets’ OTCQB. The Company has its corporate head office in Tucson, Arizona.

The Company’s solutions include the ValiMed™ Medication Validation System product line. This is marketed to healthcare markets globally for use in combatting diversion of controlled substances and narcotics. Its solutions also include compounded liquid pharmaceuticals to help ensure patient safety, and the ID²™ product line marketed to the worldwide security market for use in detecting illegal or illicit drugs in difficult-to-monitor, critical environments. 

ValiMed™ validates high-risk medications before leaving the pharmacy. It also monitors and discourages the diversion of controlled substances through validating the returned (unused) narcotics from patient treatment areas and surgery suites. The ValiMed™ Medication Validation System detects human mishaps, considerably raising the bar on medication safety and pharmaceutical drug loss prevention.

Regarding the ID² Meth Scanner, it is a hand-held, battery-operated methamphetamine detector. The same advanced technology used in ValiMed™ is applied to detect trace quantities (low nanogram range) of meth in real time, without the risk of harmful contact via skin absorption or inhalation from testing. The ID² Meth Scanner is a highly sensitive testing device. It is calibrated for precision measuring and convenient operation in detecting trace amounts of methamphetamines.

Last month, CDEX announced the expansion of its technical development team with the appointment of John Coates, Ph.D. as Technical Director for Spectroscopy Products. Dr. Coates is an internationally recognized spectroscopist and instrumentation expert. He has 40-years' experience in the fields of applied spectroscopy and analytical method development. Dr. Coates will guide the continuing development of CDEX’s spectral management systems for medication analysis and validation, with a precise focus on attaining optimal performance of the ValiMed™ Medical Validation System product line. 

CDEX, Inc. (CDEX), closed Tuesday's trading session at $0.07, even for the day, on 363 volume with 2 trades. The average volume for the last 60 days is 19,154 and the stock's 52-week low/high is $0.009/$0.08.

Integral Technologies, Inc. (ITKG)

Wall Street Resources and SmallCapVoice reported earlier on Integral Technologies, Inc. (ITKG), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Bellingham, Washington based Integral Technologies, Inc. is an emerging leader in hybrid conductive plastics. The Company and wholly owned subsidiary, ElectriPlast Corp., engage in the discovery, development, and commercialization of electrically conductive hybrid plastics used chiefly as raw materials in the production of industrial, commercial, and consumer products and services globally. Integral‘s principal product line is ElectriPlast™ with Flexible Content Technology™.  The Company has an extensive Intellectual Property (IP) portfolio referencing its ElectriPlast technology. Integral Technologies lists on the OTC Markets’ OTCQB.

ElectriPlast™ with Flexible Content Technology™ is a family of non-corrosive, electrically-conductive resin-based materials. Its properties allow it to be molded into any of the innumerable shapes and sizes associated with plastics, rubbers and other polymers while reducing component weight by 40 percent to 60 percent.

Integral Technologies and Hanwha L&C earlier signed a 10-year agreement. This agreement grants Hanwha L&C an exclusive right to sell, distribute, and manufacture ElectriPlast in South Korea. Additionally, Hanwha acquired non-exclusive sales and distribution rights to ElectriPlast in Japan, Taiwan, and China. Hanwha L&C is part of the Hanwha Group of companies that together form one of the largest conglomerates in South Korea.

Applications for ElectriPlast include Shielding Wire, Power Electronics, Connectors, and Cables; Shielding, Conduction, Batteries, and Semiconductors. Applications additionally include Heated Elements, Sensors, Antennas, Medical Devices, Consumer Electronics and Acoustics, Fuses, Capacitors, Resistors, RFID, Busbars and Terminals.  

Integral and its wholly owned subsidiary ElectriPlast announced in November 2013, that after extensive training sessions at the ElectriPlast production facility at Jasper Rubber Products, Inc. with Hanwha L&C, Integral successfully transferred to Hanwha, the science and its proprietary processes and documentation required for the manufacture of ElectriPlast. Integral is expanding its manufacturing agreement with Jasper Rubber Products, allowing Jasper to manufacture ElectriPlast at more than one facility.

Furthermore, Integral Technologies and ElectriPlast have its’ new Detroit Technology Center. The facility has been instituted to expand Integral's research and engineering capabilities and enhance its applications development and technical support. The ElectriPlast Tech Center, launched in January, has been instrumental in supporting key partnerships with BASF, Hanwha and Delphi, as well as developing other key relationships. The Tech Center is generating income from ElectriPlast sales and engineering services.

In addition, in April of this year, Integral Technologies and ElectriPlast announced that Hanwha L&C launched its dedicated production line for ElectriPlast. In April, Hanwha launched the ElectriPlast manufacturing line in South Korea.

Integral Technologies, Inc. (ITKG), closed Tuesday's trading session at $0.41, down 2.38%, on 49,302 volume with 16 trades. The average volume for the last 60 days is 134,489 and the stock's 52-week low/high is $0.24/$0.485.

Revolutions Medical Corp. (RMCP)

PennyStocks24, Pumps and Dumps, 007 Stock Chat, PennyStockSpy, StockHideout, and Stock Roach reported recently on Revolutions Medical Corp. (RMCP), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Revolutions Medical Corp. engages in the design, development, and commercialization of auto retractable vacuum safety syringes. Its dedication is to developing and distributing new products and tools for the medical industry, whether internally or through acquisitions. The Company operates in two areas: safety-engineered medical devices, including its RevVac™ safety syringe, and medical imaging enhancement. This includes proprietary software solutions that significantly enhance the ability of medical professionals to use standard MRI images for diagnosis assistance. Revolutions Medical has its corporate headquarters in Charleston, South Carolina.

Its RevVac™ safety syringe employs vacuum technology to retract the needle into the plunger after use. The syringe cannot be reused once the vacuum is activated. Revolutions Medical believes that its safety syringe should largely eliminate accidental needle stick injuries. Furthermore, it believes it will help in decreasing the spread of contagious diseases. In addition, it believes that with the help of government regulatory initiatives and individual state law reforms the safety syringe market will grow in the foreseeable future domestically and internationally.

The Company is working on developing, enhancing, and securing its proprietary MRI software tools for commercial launch. It believes that once clinical application validations using its MRI software family of products, including RevColor, RevDisplay, and Rev3D directed at concussions, stroke, Alzheimer's and breast disease are attained, these products could ultimately assist in the enhanced diagnosis, detection, and monitoring of such diseases and afflictions.

Revolutions Medical has commenced sales of its 3ml RevVac™ safety syringe through introducing and signing distributors, advertisements by way of its online sales program, attendance at many industry trade shows, and direct marketing campaigns. The Company will engage in full scale production for its 1ml, 5ml and 10ml RevVac™ safety syringes. When all sizes of the RevVac™ safety syringe are in production, Revolutions Medical believes that it can ship 50 million RevVac™ safety syringes for the following twelve month period.

Revolutions Medical announced earlier this year that it received notification that its auto retractable vacuum safety syringe patent was granted and issued in Australia, and its patent claims were accepted and will be granted and issued in Taiwan. The Company now has five countries in which the RevVac™ safety syringe has additional international patent protection outside of the U.S. This includes China, Japan, and Mexico.

Last week, Revolutions Medical announced that, to date, it is having its best quarter ever in terms of sales of its award winning RevVac™ auto retractable vacuum safety syringe. Through its marketing efforts over the past two years the interest and market activity is increasing. With new disease threats like Ebola and the upcoming flu season, Revolutions Medical is seeing greater interest in the RevVac™ safety syringe than ever before.

Revolutions Medical Corp. (RMCP), closed Tuesday's trading session at $0.0041, down 18.00%, on 2,407,905 volume with 25 trades. The average volume for the last 60 days is 1,056,462 and the stock's 52-week low/high is $0.0035/$0.05.

OriginOil, Inc. (OOIL)

Investor News Source, Penny Stocks Finder, Stock Preacher, Beacon Equity Research, InvestorSoup, Penny Stock Craze, SuperStock Tips, AskSlapper, PennyStockSpy, 007 Stock Chat, and PennyStocks24 reported this month on OriginOil, Inc. (OOIL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OriginOil, Inc. is the developer of an innovative energy production process for harvesting algae and cleaning up oil & gas water. This process operates at the first stage of extraction. The high-speed and chemical-free process can be embedded in other systems to improve performance. The Los Angeles, California based Company has developed a unique process for removing up to 99 percent of contaminants from the very large quantities of water used by the oil & gas, algae, and other water-intensive industries. OriginOil’s shares trade on the OTCQB.

For the oil & gas industry, OriginOil is helping clean up produced water and recycle fracking water to reduce harm to the environment and lower costs. For the developing algae industry, the Company is making large-scale harvest possible. In addition, in aquaculture, it is helping improve yields and making seafood healthier through substantially reducing the levels of toxic ammonia and bacteria in water.

The basis of OriginOil's CLEAN-FRAC process is on its Electro Water Separation™ (EWS) technology. This technology efficiently removes oils, suspended solids, insoluble organics, and bacteria from produced or 'frac flowback' water, on a continuous flow basis and without the use of chemicals. EWS is the high-speed, chemical-free process to clean up large quantities of water.

The Company’s EWS works in two parts. First, contaminated water enters the first stage, Electro-Coagulation (EC). In this stage, electrical impulses are applied in long tubes, causing the organic contaminants to coagulate, or “clump” together. In 2009, OriginOil branded this stage Single-Step Extraction™. Second, the clumped-up material travels into a tank where electrical pulses generate a cloud of micro-bubbles that gently lifts the concentrate to the surface for harvesting.

OriginOil announced in May plans to launch a product line that can treat frack water from end to end. The basis of the product, CLEAN-FRAC™, is on the Company’s P1000 platform. The design of this platform is to process 1,000 barrels per day of frac flowback and produced water.

This month, OriginOil announced that it will provide algae harvesting technology for the low-cost algae growth system from Algasol Renewables. The integrated system will launch at Algasol’s new facilities in Bangladesh- an innovative, large-scale demonstration of micro-algae production for fish feed. Moreover, this month, OriginOil announced that in a letter to shareholders, CEO Riggs Eckelberry reported on the Company's recent entry into the frack water cleanup market in China. Co-founder Nicholas Eckelberry reported on his recent testing mission to China and its results.

OriginOil, Inc. (OOIL), closed Tuesday's trading session at $0.205, up 2.50%, on 827,622 volume with 136 trades. The average volume for the last 60 days is 571,517 and the stock's 52-week low/high is $0.121/$0.36.

Endeavor IP, Inc. (ENIP)

Greenbackers, Pumps and Dumps, AnotherWinningTrade, Investment House, Market FN, Stock Research Newsletter, The Best Newsletters, YOLOTraderAlerts, Todd Horwitz, The Stock Enthusiast, The Trading Report, HoleinOneStocks.net, and Wyatt Investment Research reported earlier on Endeavor IP, Inc. (ENIP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 2009, New York City based Endeavor IP, Inc. is an intellectual property (IP) services and patent licensing company. It engages in the acquisition and licensing of IP. Endeavor combines investment strategy, technology and best practices in the monetization of patents. Its focus is on investors, inventors, and its patent partners. Endeavor IP only defends patents with the potential to yield highly successful results. The Company formerly went by the name Finishing Touches Home Goods, Inc. It changed its corporate name to Endeavor IP, Inc. in May of 2013.

Endeavor IP offers a portfolio approach to IP investing, which lessens risk and maximizes returns. It is technology agnostic and applies modern investment management techniques to the patent sector. The Company’s leadership team includes individuals from science and law to financial analysis and technology. Endeavor IP believes in protecting and aggressively enforcing the IP rights of inventors.

Endeavor IP announced in November 2013, that it was issued a Notice of Allowance from the United States Patent and Trademark Office (USPTO). The Notice of Allowance pertains to the Company’s wholly-owned subsidiary Endeavor MeshTech and the patent titled Wireless Communication Enabled Meter and Network.

Last month, Endeavor IP announced that its subsidiary Endeavor MeshTech entered into a license and settlement agreement with Sensus USA, Inc. Mr. Rob Dhat, Endeavor IP’s Chief Executive Officer, said, "This agreement highlights our ongoing commitment to monetizing and licensing our intellectual property. Entering into this agreement with Sensus marks the third settlement Endeavor has entered into with respect to its MeshTech portfolio and further demonstrates the strength of its intellectual property."

This month, Endeavor IP announced operating developments and results for fiscal Q3 ending July 31, 2014. Revenue from settlements and licensing was $0.7M. The Company achieved gross margins of approximately 74 percent and income from operations of $65,761. Cash used in operating activities was $519,461. Net loss from continuing operations was roughly $1.1 million.

The net loss was primarily attributable to around $269K in interest expense on outstanding notes payable and approximately $443K in non-cash stock based compensation.

Endeavor IP, Inc. (ENIP), closed Tuesday's trading session at $0.02, up 0.50%, on 107,950 volume with 15 trades. The average volume for the last 60 days is 366,984 and the stock's 52-week low/high is $0.012/$1.28.

DelMar Pharmaceuticals, Inc. (DMPI)

Streetwise Reports and Wall Street Resources reported earlier on DelMar Pharmaceuticals, Inc. (DMPI), and we are reporting on the Company also, here at the QualityStocks Daily Newsletter.

Founded in 2010, DelMar Pharmaceuticals, Inc.'s emphasis is to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. Its lead asset is VAL-083. At present, VAL-083 is undergoing clinical trials in the United States as a potential treatment for refractory glioblastoma multiforme (GBM). GBM is the most common and aggressive form of brain cancer. VAL-083 is currently approved for the treatment of chronic myelogenous leukemia (CML) and lung cancer in China. OTCQB listed, DelMar Pharmaceuticals is based in Vancouver, British Columbia.  

The Company’s product candidate, VAL-083, benefits from an historical investment of more than US$50 million by the National Cancer Institute (NCI) in the U.S. The drug is well characterized. It has undergone study in greater than 40 Phase I and Phase II NCI-sponsored human clinical trials in the U.S. and in Europe.

Published pre-clinical and clinical data suggest that VAL-083 may be active against a variety of tumor types via a novel mechanism of action. VAL-083 target markets are the Glioblastoma Multiforme (GBM), additional Orphan Drug Indications – AML, as well as Lung Cancer. The Company continues to advance its clinical trials with VAL-083 as a potential new treatment for Refractory Glioblastoma Multiforme.

DelMar Pharmaceuticals is now delivering almost twice the amount of VAL-083 than was administered in previous U.S. National Cancer Institute (NCI)-sponsored clinical trials (240 mg/m2 vs 125 mg/m2) in comparison to the NCI's 33-day cycle. The Company continues to explore the potential utility of VAL-083 in new indications in an effort to expand the agent's commercial potential in China.

Promising interim results of DelMar Pharmaceuticals’ continuing clinical trial with VAL-083 were presented at the annual meetings of both the American Association of Cancer Research (AACR) in April 2014 and the American Society of Clinical Oncology (ASCO) in May 2014. Data presented to date demonstrate that VAL-083 is safe and well tolerated at doses up to 40mg/m2. Furthermore, one of three patients in the 30mg/m2 dose cohort and one of three patients in the 40mg/m2 dose cohort demonstrated stable disease after only one or two cycles of treatment.

Last month, DelMar announced that a protocol amendment to allow for expanded dosing in its VAL-083 clinical trial had been filed with the U.S. Food and Drug Administration (FDA). It also announced that a new cohort of a new 50mg/m2 has been opened at three clinical trial sites in the U.S. Additionally, DelMar confirmed that gross proceeds of US$2.9 million were raised through warrant exercise in two separate closings. These funds provide adequate working capital to fund its current operations, including its glioblastoma clinical trial, through at least December 2015.

DelMar Pharmaceuticals, Inc. (DMPI), closed Tuesday's trading session at $0.95, down 3.06%, on 29,172 volume with 14 trades. The average volume for the last 60 days is 29,103 and the stock's 52-week low/high is $0.622/$1.60.


The QualityStocks
Company Corner


Cannabics Pharmaceuticals, Inc. (CNBX)

The QualityStocks Daily Newsletter would like to spotlight Cannabics Pharmaceuticals, Inc. (CNBX). Today, Cannabics Pharmaceuticals, Inc. closed trading at $0.3289, up 9.63%, on 1,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 11,775, and its 52-week low/high is $0.03/$1.40.

Cannabics Pharmaceuticals, Inc. (CNBX) was founded in 2012 by a team of experts in the fields of molecular biology, cancer research and pharmacology, who recognized the potential of cannabinoid-based therapies for debilitating and incurable ailments. Through the course of its research, the company’s pharmacology team has amassed valuable knowledge in the development of advanced delivery systems for active cannabinoids that provide improved treatment options for patients wishing to utilize the unique medical properties of the cannabis plant.

Leveraging this expertise and knowledge, Cannabics Pharmaceuticals has created a wide range of solutions for standardized, reproducible and easily administered medical cannabis therapies. The company’s flagship product, Cannabics SR, contains a pure concentrate of cannabinoids derived from select cannabis strains, embedded in a sophisticated formulation which provides beneficial therapeutic effects for 10-12 hours upon a single oral administration.

The excipients of the proprietary Cannabics SR formulation are all certified food-grade ingredients and are free of artificial additives or chemical substances. Cannabics’ proprietary technologies are developed in certified laboratories and are licensed to certified manufacturers and distributors with adequate licenses in their local territories. Cannabics Pharmaceuticals itself does not manufacture, distribute, dispense or possess any controlled substances, including cannabis and cannabis-based preparations.

Co-founders Dr. Zohar Koren (CEO) and Dr. Eyal Ballan (CTO) guide the company’s operations with vast experience in business and pharmaceutical development, strategic consulting, venture capital, evolutionary and environmental sciences, anti-cancer drug development and molecular biology. Under their leadership, Cannabics Pharmaceuticals continues to develop its genetic and phenotipic database to provide superior treatments for incapacitating ailments for which there is no cure. Disclaimer

Cannabics Pharmaceuticals, Inc. Company Blog

Cannabics Pharmaceuticals, Inc. News:

Cannabics Pharmaceuticals recruits two former senior Teva Executives to its Advisory Board

Cannabics Pharmaceuticals Inc. (CNBX) Focused on Developing Cannabinoid-based Therapies

WRIT Media Group, Inc. (WRIT)

The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.02, up 33.33%, on 86,093 volume with 8 trades. The stock’s average daily volume over the past 60 days is 38,099, and its 52-week low/high is $0.015/$0.50.

WRIT Media Group, Inc., Retro Infinity Inc., a wholly-owned subsidiary of WRIT and publisher of classic video games on today's mobile devices, including the Amiga Games brand, announced today that it has teamed with Rick Ware Racing ("RWR") for eight major racing events in the US & Europe. The RWR Retro Infinity "Drive to Championship Weekend" will encompass eight select motorsports events, including NASCAR Sprint Cup, NASCAR Nationwide Series, NASCAR Camping World Truck Series, and the NASCAR Whelan Euro Series race.

WRIT Media Group, Inc. (WRIT) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.

The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.

Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.

Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.

Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer

WRIT Media Group, Inc. Company Blog

WRIT Media Group, Inc. News:

WRIT Media Announces Schedule for NASCAR On-Car and Driver Logo Branding

WRIT Media Retains Digney & Company as Public Relations Agency

WRIT Media Enters NASCAR's Top Series in US & Europe

Intelligent Highway Solutions, Inc. (IHSI)

The QualityStocks Daily Newsletter would like to spotlight Intelligent Highway Solutions, Inc. (IHSI). Today, Intelligent Highway Solutions, Inc. closed trading at $0.055, on 88,000 volume with 10 trades. The stock’s average daily volume over the past 60 days is 84,335, and its 52-week low/high is $0.05/$0.899.

Intelligent Highway Solutions, Inc. today announced it has entered into an agreement with Smith, Dawson & Andrews, a Washington D.C.-based government relations firm, to assist IHSI in the exploration and execution of additional industry contracts and opportunities. Piggy-backing the success of its relationship with Honeywell International, Inc. to bring the tech giant's California buildings to code with Title 24 regulations, IHSI will leverage its new partnership to continue expanding its reach to other municipal, state and federal sector buildings with similar needs.

Intelligent Highway Solutions, Inc. (IHSI) is a diversified technology-based electrical contracting company focused on the development and implementation of high and low voltage solutions across multiple platforms. Aside from years of business management and financing experience, IHSI’s executive team has more than 80 years of combined electrical background, creating the perfect backdrop and catalyst for the company’s recent entrance into the overlooked yet critical lighting segment of the billowing medical marijuana industry.

Through the development of proprietary wireless vehicle detection systems designed to make the nation's roadways more efficient, IHSI developed deep relationships with the transportation markets of local and state governments. These business relationships played a significant role in IHSI securing exclusive distribution rights to lighting systems developed by SCS Lighting Solutions, an engineering and electronics company specializing in solid state diode (SSD) lighting solutions.

The initial focus of the business relationship was for IHSI to offer SCS’s highly efficient, long-lasting lighting solutions to municipalities as a means to drastically reduce energy and maintenance costs. As a result, when the new business opportunity arrived to provide a low cost, energy efficient lighting technology for accelerating the growth of cannabis plants, IHSI already had the expertise and infrastructure needed to create a superior light for this specific purpose.

Currently estimated to generate annual sales of $1.5 billion in the U.S. alone, the medical marijuana industry is one of the world’s fastest growing markets. Leveraging a C-level team of electrical contractors backed by years of business management expertise, IHSI is positioned to cultivate sustainable growth in a key segment of the medical marijuana industry through its exclusive distribution rights to proprietary lighting systems designed to help legal cannabis growers reduce costs and improve yields. Disclaimer

Intelligent Highway Solutions, Inc. Company Blog

Intelligent Highway Solutions, Inc. News:

Intelligent Highway Solutions Announces Agreement With a Washington D.C. Based Government Relations Firm

Intelligent Highway Solutions Installs 300W Grow Light at Medical Cannabis Growing Facility to Enhance Greater Yields

Intelligent Highway Solutions Announces Successful Test of Cannabis Lights and Additional Testing to Produce Greater Yields With New Prototype of Grow Light

Oriens Travel and Hotel Management Corp. (OTHM)

The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0001, on 6,069,230 volume with 23 trades. The stock’s average daily volume over the past 60 days is 24,670,037, and its 52-week low/high is $0.0001/$0.0024.

Oriens Travel and Hotel Management Corp. announced today that the Company has named Mr. Melvin Pereira as its new Chief Executive Officer, President & Director. As a result of the Company accepting a "Plan of Merger" during a special meeting of the Board of Directors, on Wednesday, September 10th, 2014; the nomination of Melvin Pereira was also made.

Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.

The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.

Operating a successful bi-lateral business model, Oriens has four objectives:

1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;

2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;

3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,

4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.

The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.

Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer

Oriens Travel and Hotel Management Corp. Company Blog

Oriens Travel and Hotel Management Corp. News:

International Hospitality Company Oriens Announces New CEO

Oriens' Merger Set to Close

Oriens' Board Accepts Plan of Merger

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.03, up 50.00%, on 232,099 volume with 20 trades. The stock’s average daily volume over the past 60 days is 644,666, and its 52-week low/high is $0.009/$0.96.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India

Big Tree Group, Inc. (BIGG)

The QualityStocks Daily Newsletter would like to spotlight Big Tree Group, Inc. (BIGG). Today, Big Tree Group, Inc. closed trading at $0.0098, up 30.67%, on 8,280,066 volume with 155 trades. The stock’s average daily volume over the past 60 days is 2,005,602, and its 52-week low/high is $0.006/$0.45.

Big Tree Group, Inc. (BIGG) is an authorized sales agent for thousands of toy manufacturers in China, providing multiple procurement services for international toy distributors and wholesalers. Headquartered in Shantou City, known as the Toy Capital of the world, Big Tree operates a 21,000-square-foot showroom to display its products to thousands of international toy purchasers. The sprawling facility includes an onsite testing laboratory where all toys undergo rigorous testing to ensure both quality and function before reaching the showroom floor.

Big Tree is a “one-stop-shop” for the international sourcing and distribution of toys and other related products. As an authorized agent, Big Tree currently represents more than 8,000 toy manufacturers, offering more than 300,000 varieties of toy products such as remote control toys, digital toys, sports toys, play sets, educational toys, dolls and infant toys. Big Tree conducts its operations through its two fully operating subsidiaries, Big Tree Brunei and Big Tree Shantou.

In 2011, Big Tree began selling its own patented construction toy, the Magic Puzzle (3D). The proprietary Big Tree Magic Puzzle is promoted and distributed solely in the Chinese domestic market, available through Big Tree Shantou’s online store and at several retail locations. The product has been well-received, and Big Tree is also evaluating global marketing and distribution of the Magic Puzzle.

Big Tree’s operations are spearheaded by long-time China toy industry veteran and company CEO Wei Lin, who founded the toy export and import company Shantou Dashu Toy Corp. Ltd. He is supported by a seasoned and experienced management team proficient in operations management, marketing, sales, team management, education and accounting. This leadership team has established an aggressive growth strategy to expand Big Tree’s sales and global product distribution by utilizing its expansive multi-lingual sales team and by leveraging industry contacts to identify strategic mergers and acquisitions, and maximize trade and industry opportunities.

As the world’s leading toy manufacturer and exporter, China produces and distributes two-thirds of the multi-billion dollar toy industry’s global demand. The nation’s manufacturing is highly regional, with 70 percent of toy sales in China generated in the Guangdong province. Strategically located in this province, Big Tree has cultivated an extensive customer base in Asia and Europe and is planning global expansion and distribution, especially in the Americas. Disclaimer

Big Tree Group, Inc. Company Blog

Big Tree Group, Inc. News:

Market Advisors, Inc. Issues Report on Big Tree Group

Big Tree Group Launches New Domestic Online Ecommerce Platform

Big Tree Group Receives Purchase Orders from Costa Rican Retail Chain Valued at Approximately $400,000

WordLogic Corp. (WLGC)

The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.07, up 6.06%, on 138,625 volume with 6 trades. The stock’s average daily volume over the past 60 days is 56,609, and its 52-week low/high is $0.065/$0.26.

WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.

The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.

For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.

Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer

WordLogic Corp. Company Blog

WordLogic Corp. News:

WordLogic the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group

WordLogic Files Patent Infringement Lawsuit Against TouchType Ltd., Makers of SwiftKey

WordLogic Announces Development of iOS 8 Version of Award-Winning iKnowU Keyboard


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Real Pennies





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251